Product image of Menopur (Menotrophin) supplied by GNH India

Menopur

Active Ingredient:
Menotrophin
Origin:
EU

Menopur (Menotrophin)

Menotropin, the active ingredient in Menopur, is a gonadotropin presented as an injectable powder for solution for injection for intramuscular or subcutaneous administration. It provides exogenous FSH and LH activity to stimulate ovarian follicular development and estrogen production, supporting ovulation induction and controlled ovarian hyperstimulation in women with infertility.

GNH India supplies Menopur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and regulatory requirements across EU and global markets.

Manufacturer / TM Owner

Ferring Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Menopur is a gonadotropin used in reproductive medicine to support follicular growth and ovulation.

  • Anovulation: induces ovulation in women with anovulatory infertility.
  • Controlled ovarian hyperstimulation: enhances follicular development for assisted reproductive technologies such as IVF.
  • Induction of ovulation in infertility treatment: facilitates ovulation in patients undergoing fertility therapy.

How It Works

  • Menotropin contains both follicle‑stimulating hormone (FSH) and luteinizing hormone (LH) subunits. After subcutaneous or intramuscular injection, the FSH component binds to FSH receptors on granulosa cells, promoting follicular recruitment and growth, while the LH component activates LH receptors on theca cells, stimulating androgen production that is aromatized to estrogen. The combined activity mimics the natural pituitary gonadotropin surge, leading to follicular maturation and ovulation.

Side Effects

Menopur may be associated with a range of adverse reactions, which are generally related to its hormonal activity and injection site.

Common Side Effects

  • Injection site pain: mild to moderate discomfort at the injection site.
  • Abdominal bloating: transient abdominal distension.
  • Headache: mild headache episodes.
  • Nausea: occasional nausea.
  • Mood changes: mild emotional lability.
  • Ovarian hyperstimulation symptoms: mild ovarian enlargement.

Serious or Rare Side Effects

  • Ovarian hyperstimulation syndrome (OHSS): severe fluid shift and thrombosis risk.
  • Multiple pregnancy: increased chance of twins or higher‑order gestations.
  • Thromboembolic events: rare blood clot formation.
  • Allergic reaction: anaphylaxis or severe hypersensitivity.

Precautions & Warnings

Prior to initiating Menopur therapy, clinicians should consider several precautionary measures to ensure patient safety.

  • Baseline assessment: perform ultrasound and hormone evaluation before treatment.
  • Ovarian monitoring: conduct regular ultrasound to detect excessive follicular response.
  • OHSS risk: assess patient history for risk factors such as polycystic ovary syndrome.
  • Pregnancy testing: confirm negative pregnancy test before starting therapy.
  • Concomitant hormones: avoid use with other gonadotropins unless medically indicated.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Menopur can interact with other medications that affect hormonal balance or coagulation.

Major Interactions (Avoid)

  • GnRH agonists/antagonists: may alter gonadotropin response if not coordinated.
  • Anticoagulants: increased risk of bleeding with severe OHSS.
  • Estrogen‑containing products: may interfere with intended hormonal stimulation.

Moderate Interactions (Monitor Closely)

  • Thyroid hormones: monitor thyroid function as gonadotropins can affect metabolism.
  • Corticosteroids: may mask OHSS symptoms.
  • Diuretics: can influence fluid balance during OHSS.

Frequently Asked Questions

Menopur is prescribed to treat infertility by stimulating ovarian follicular development. It is used for anovulation, controlled ovarian hyperstimulation in assisted reproductive technologies such as IVF, and for ovulation induction in women who have difficulty ovulating naturally.

Menotropin contains both FSH and LH activity. After injection, the FSH component promotes growth of ovarian follicles, while the LH component supports the conversion of androgens to estrogen. Together they mimic the natural pituitary surge, leading to mature follicles and ovulation.

The dose of Menopur is individualized. A qualified prescriber determines the amount and frequency based on the patient’s ovarian response, treatment protocol, and monitoring results. No fixed regimen is provided in public information.

Menopur is intended for use before pregnancy to achieve ovulation. Its safety during pregnancy has not been established, and it is generally not continued once pregnancy is confirmed. Limited data are available for breastfeeding, so use is usually avoided.

To order Menopur, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Menopur is a highly purified menotropin preparation containing both FSH and LH activity, whereas many alternatives, such as recombinant FSH products, provide only FSH. Menopur’s combined activity can reduce the need for additional LH supplementation, but dosing and response may differ between products.

Menopur should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. After reconstitution, the solution should be used promptly or stored according to the manufacturer’s instructions, typically within 24 hours at the same temperature.

Menopur is supplied as a sterile powder that must be reconstituted with the provided diluent. The resulting solution is injected subcutaneously or intramuscularly, usually in the abdominal wall or thigh, following the dosing schedule prescribed by the treating physician.

The most serious risks include ovarian hyperstimulation syndrome (OHSS), which can cause severe fluid shifts and thromboembolic events, and the increased likelihood of multiple pregnancies. Prompt monitoring and early detection of symptoms are essential to mitigate these risks.

Menopur is contraindicated in individuals with known hypersensitivity to menotropin or any excipients, in women who are already pregnant, and in patients with uncontrolled thyroid disease or severe ovarian cysts. Caution is also advised for those with a history of thromboembolic disorders.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Menotrophin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT